project x bpc 157 in Australia: Benefits, side effects, risks and legality bpc-157 chronic fatigue syndrome Project
Description
The MHRA has acknowledged this association in a Drug Safety Update, highlighting the importance of awareness and appropriate monitoring
Aljabari B, Calogero AE, Perdichizzi A, et al
Using any unlicensed injectable compound carries inherent and serious risks
The promotion and prescription of BPC-157 without FDA approval undermines these regulatory processes
